CELLMOVER AS
Pre-clinical immunotherapy company optimizing immune cell targeting for cancer.
Overview
- 7
- Employees
- 4.5M NOK
- Revenue
- 2015
- Founded
Key Decision Makers
Miriam Aarsund Larsen
CEO
Marit Inngjerdingen
Founder & Chairman
Eirik Næss-Ulseth
BD Advisor
Eline M. Scheie-Ahlgren
Associate scientist
+2 more contacts in Funnelfeedr
Description
Cellmover is a pre-clinical stage immunotherapy company based in Oslo, Norway. Their core mission is optimizing the tools of the immune system to expand the application of immunotherapies across various cancers. The company has developed a proprietary library of nanobodies and peptides specifically...